/Investor DB

Fall Line Capital — 2018 Investments

1 investments dated 2018 · listed companies and verified rows first · show all

Benson Hill Biosystemsbensonhillbio.cominSep 2018 · $60M

Confluence Genetics (operating at bensonhillbio.com) is a seed innovation company that develops soybean genetics using AI-driven plant science and proprietary tools such as eMERGE Genetics and CropOS.

Durham, US

Matthew B Crisp(Executive Officer, Director)Lee Palles(Executive Officer)inNadine Carozzi(Executive Officer)Todd C Mockler(Executive Officer)Thomas Brutnell(Executive Officer)

BoardDaniel J Broderick(Director)

Co-investorsActivant CapitalAlexandriaBioGenerator VenturesCultivation CapitalGV (Google Ventures)iSelect Fund+7 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.